An 8-fold increase of T-bet level, together with a 5.58-fold increase of CD4 level was observed in tumor tissues of siRNA2@HPVP-treated mice, as compared with that of the PBS group (Fig. 4h). The gene discussed is CD4; the disease is neoplasm.